Close Menu

The overall success rate of getting an NIH grant funded in 2009 was 20.6 percent, reports Writedit at Medical Writing, Editing & Grantsmanship. She breaks the data down further to find that R21s have success rates below those of R01s and lists grant success rates for R21s at some of the major institutes: 14.5 percent at NHLBI, 13.7 percent at NCI, and 7.9 percent at NIGMS. NIMH has a high R21 success rate, coming in at 20.1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.